ClinicalTrials.Veeva

Menu

Clinical Study on the Safety of SAFIL® MESH (SAFIL_MESH)

Aesculap logo

Aesculap

Status

Completed

Conditions

Fascial Hernia
Ventral Hernia
Abdominal Wall Defect
Abdominal Hernia

Treatments

Device: Hernioplasty

Study type

Observational

Funder types

Industry

Identifiers

NCT04947202
AAG-O-H-2040

Details and patient eligibility

About

Observational, Retrospective, Multi-center Clinical Study on the Safety of SAFIL® MESH in Patients Undergoing Reinforcement of Soft Tissues After Abdominal Wall Surgery or Other Fascial Defects

Full description

The study design is a retrospective case-note series of patients that have undergone reinforcement of soft tissues with Safil® Mesh after abdominal wall surgery or other fascial defects between the period January 2019 - November 2020

Enrollment

152 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients operated between January 2019 - November 2020 for abdominal wall surgery or other fascial defects and received Safil® Mesh

Exclusion criteria

  • No exclusion criteria have been set.

Trial design

152 participants in 1 patient group

Safil Mesh
Treatment:
Device: Hernioplasty

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems